SIL index, comprising stage, soluble interleukin‐2 receptor, and lactate dehydrogenase, is a useful prognostic predictor in diffuse large B‐cell lymphoma

بواسطة Tomita, Naoto, Sakai, Rika, Fujisawa, Shin, Fujimaki, Katsumichi, Taguchi, Jun, Hashimoto, Chizuko, Ogawa, Koji, Yamazaki, Etsuko, Ishigatsubo, Yoshiaki
الحاوية / القاعدة Cancer Sci (2012)

Changing trends in prognostic factors for patients with multiple myeloma after autologous stem cell transplantation during the immunomodulator drug/proteasome inhibitor era

بواسطة Takamatsu, Hiroyuki, Honda, Sumihisa, Miyamoto, Toshihiro, Yokoyama, Kenji, Hagiwara, Shotaro, Ito, Toshiro, Tomita, Naoto, Iida, Shinsuke, Iwasaki, Toshihiro, Sakamaki, Hisashi, Suzuki, Ritsuro, Sunami, Kazutaka
الحاوية / القاعدة Cancer Sci (2015)

Post-treatment PET–CT Findings may Predict the Prognosis of DLBCL with a Bulky Mass

بواسطة Takasaki, Hirotaka, Yamamoto, Wataru, Ishii, Yoshimi, Takahashi, Hiroyuki, Watanabe, Reina, Harada, Taishi, Kawasaki, Rika, Hashimoto, Chizuko, Motomura, Shigeki, Tomita, Naoto, Ishigatsubo, Yoshiaki, Sakai, Rika
الحاوية / القاعدة Indian J Hematol Blood Transfus (2014)

Clinicopathological features of lymphoma/leukemia patients carrying both BCL2 and MYC translocations

بواسطة Tomita, Naoto, Tokunaka, Mami, Nakamura, Naoya, Takeuchi, Kengo, Koike, Junki, Motomura, Shigeki, Miyamoto, Ko, Kikuchi, Ako, Hyo, Rie, Yakushijin, Yoshihiro, Masaki, Yasufumi, Fujii, Soichiro, Hayashi, Takamasa, Ishigatsubo, Yoshiaki, Miura, Ikuo
منشور في 2009

MIB‐1 labeling index as a prognostic factor for patients with follicular lymphoma treated with rituximab plus CHOP therapy

بواسطة Yamamoto, Eri, Tomita, Naoto, Sakata, Seiji, Tsuyama, Naoko, Takeuchi, Kengo, Nakajima, Yuki, Miyashita, Kazuho, Tachibana, Takayoshi, Takasaki, Hirotaka, Tanaka, Masatsugu, Hashimoto, Chizuko, Koharazawa, Hideyuki, Fujimaki, Katsumichi, Taguchi, Jun, Harano, Hiroshi, Motomura, Shigeki, Ishigatsubo, Yoshiaki
الحاوية / القاعدة Cancer Sci (2013)

European Treatment and Outcome Study score does not predict imatinib treatment response and outcome in chronic myeloid leukemia patients

بواسطة Yamamoto, Eri, Fujisawa, Shin, Hagihara, Maki, Tanaka, Masatsugu, Fujimaki, Katsumichi, Kishimoto, Kumiko, Hashimoto, Chizuko, Itabashi, Megumi, Ishibashi, Daisuke, Nakajima, Yuki, Tachibana, Takayoshi, Kawasaki, Rika, Kuwabara, Hideyuki, Koharazawa, Hideyuki, Yamazaki, Etsuko, Tomita, Naoto, Sakai, Rika, Fujita, Hiroyuki, Kanamori, Heiwa, Ishigatsubo, Yoshiaki
الحاوية / القاعدة Cancer Sci (2014)